472 related articles for article (PubMed ID: 28363317)
1. Validation of prescriber risk indicators obtained from prescription drug monitoring program data.
Kreiner PW; Strickler GK; Undurraga EA; Torres ME; Nikitin RV; Rogers A
Drug Alcohol Depend; 2017 Apr; 173 Suppl 1():S31-S38. PubMed ID: 28363317
[TBL] [Abstract][Full Text] [Related]
2. Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.
Paulozzi LJ; Strickler GK; Kreiner PW; Koris CM;
MMWR Surveill Summ; 2015 Oct; 64(9):1-14. PubMed ID: 26469747
[TBL] [Abstract][Full Text] [Related]
3. Opioid Prescribing Patterns and Patient Outcomes by Prescriber Type in the Oregon Prescription Drug Monitoring Program.
Fink PB; Deyo RA; Hallvik SE; Hildebran C
Pain Med; 2018 Dec; 19(12):2481-2486. PubMed ID: 29155988
[TBL] [Abstract][Full Text] [Related]
4. Effect of Florida's Prescription Drug Monitoring Program and Pill Mill Laws on Opioid Prescribing and Use.
Rutkow L; Chang HY; Daubresse M; Webster DW; Stuart EA; Alexander GC
JAMA Intern Med; 2015 Oct; 175(10):1642-9. PubMed ID: 26280092
[TBL] [Abstract][Full Text] [Related]
5. The effects of state rules on opioid prescribing in Indiana.
Al Achkar M; Grannis S; Revere D; MacKie P; Howard M; Gupta S
BMC Health Serv Res; 2018 Jan; 18(1):29. PubMed ID: 29347984
[TBL] [Abstract][Full Text] [Related]
6. Opioid Prescribing Behaviors - Prescription Behavior Surveillance System, 11 States, 2010-2016.
Strickler GK; Kreiner PW; Halpin JF; Doyle E; Paulozzi LJ
MMWR Surveill Summ; 2020 Jan; 69(1):1-14. PubMed ID: 31999681
[TBL] [Abstract][Full Text] [Related]
7. Relationship between high-risk patients receiving prescription opioids and high-volume opioid prescribers.
Chang HY; Murimi IB; Jones CM; Alexander GC
Addiction; 2018 Apr; 113(4):677-686. PubMed ID: 29193546
[TBL] [Abstract][Full Text] [Related]
8. Associations between statewide prescription drug monitoring program (PDMP) requirement and physician patterns of prescribing opioid analgesics for patients with non-cancer chronic pain.
Lin HC; Wang Z; Boyd C; Simoni-Wastila L; Buu A
Addict Behav; 2018 Jan; 76():348-354. PubMed ID: 28898808
[TBL] [Abstract][Full Text] [Related]
9. Prescriber responses to a pain clinic law: Cease or modify?
Yenerall J; Buntin MB
Drug Alcohol Depend; 2020 Jan; 206():107591. PubMed ID: 31765860
[TBL] [Abstract][Full Text] [Related]
10. Prescribing Associated with High-Risk Opioid Exposures Among Non-cancer Chronic Users of Opioid Analgesics: a Social Network Analysis.
Hinami K; Ray MJ; Doshi K; Torres M; Aks S; Shannon JJ; Trick WE
J Gen Intern Med; 2019 Nov; 34(11):2443-2450. PubMed ID: 31420823
[TBL] [Abstract][Full Text] [Related]
11. Effect of Payor-Mandated Review of Prescription Drug Monitoring Program on Opioid Prescriber Rates.
Schumann SO; Zhang J; McCauley JL; Heidari K; Ball SJ
South Med J; 2020 Sep; 113(9):415-417. PubMed ID: 32885255
[TBL] [Abstract][Full Text] [Related]
12. An Examination of Concurrent Opioid and Benzodiazepine Prescribing in 9 States, 2015.
Guy GP; Zhang K; Halpin J; Sargent W
Am J Prev Med; 2019 Nov; 57(5):629-636. PubMed ID: 31564606
[TBL] [Abstract][Full Text] [Related]
13. Impact of a prescription drug monitoring program use mandate on potentially problematic patterns of opioid analgesic prescriptions in New York City.
Bachhuber MA; Tuazon E; Nolan ML; Kunins HV; Paone D
Pharmacoepidemiol Drug Saf; 2019 May; 28(5):734-739. PubMed ID: 30920062
[TBL] [Abstract][Full Text] [Related]
14. Effects of mandatory prescription drug monitoring program (PDMP) use laws on prescriber registration and use and on risky prescribing.
Strickler GK; Zhang K; Halpin JF; Bohnert ASB; Baldwin GT; Kreiner PW
Drug Alcohol Depend; 2019 Jun; 199():1-9. PubMed ID: 30954863
[TBL] [Abstract][Full Text] [Related]
15. Effect of Controlled Substance Use Management on Prescribing Patterns and Health Outcomes Among High-Risk Users.
Chen X; Ma Q; Barron J; DeVries A; Horn J; Agiro A
J Manag Care Spec Pharm; 2019 Mar; 25(3):392-401. PubMed ID: 30816820
[TBL] [Abstract][Full Text] [Related]
16. Development of an Institutional Opioid Prescriber Education Program and Opioid-Prescribing Guidelines: Impact on Prescribing Practices.
Stepan JG; Lovecchio FC; Premkumar A; Kahlenberg CA; Albert TJ; Baurley JW; Nwachukwu BU
J Bone Joint Surg Am; 2019 Jan; 101(1):5-13. PubMed ID: 30601411
[TBL] [Abstract][Full Text] [Related]
17. Variations in prescription drug monitoring program use by prescriber specialty.
Sun BC; Lupulescu-Mann N; Charlesworth CJ; Kim H; Hartung DM; Deyo RA; John McConnell K
J Subst Abuse Treat; 2018 Nov; 94():35-40. PubMed ID: 30243415
[TBL] [Abstract][Full Text] [Related]
18. Identifying opioid prescribing patterns for high-volume prescribers via cluster analysis.
Nataraj N; Zhang K; Guy GP; Losby JL
Drug Alcohol Depend; 2019 Apr; 197():250-254. PubMed ID: 30875645
[TBL] [Abstract][Full Text] [Related]
19. The Impact of Prescription Drug Monitoring Programs and Prescribing Guidelines on Emergency Department Opioid Prescribing: A Multi-Center Survey.
Pomerleau AC; Nelson LS; Hoppe JA; Salzman M; Weiss PS; Perrone J
Pain Med; 2017 May; 18(5):889-897. PubMed ID: 26995800
[TBL] [Abstract][Full Text] [Related]
20. Changes in opioid prescribing after implementation of mandatory registration and proactive reports within California's prescription drug monitoring program.
Castillo-Carniglia A; González-Santa Cruz A; Cerdá M; Delcher C; Shev AB; Wintemute GJ; Henry SG
Drug Alcohol Depend; 2021 Jan; 218():108405. PubMed ID: 33234299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
